Skip to main content
Premium Trial:

Request an Annual Quote

DeCode Extends Deal with Affymetrix to Use GeneChip


REYKJAVIK, Iceland--DeCode Genetics has extended its contract with Affymetrix to gain access to GeneChip technology for use in gene expression monitoring and genotyping applications. The companies said they also plan to continue collaborative work focused on optimizing chip-based single-nucleotide polymorphism genotyping applications.

Kari Stefansson, president and CEO of DeCode, said the agreement fits in with DeCode's plans to add alternative gene discovery and gene function tools to its existing technology portfolio.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.